| |
PLoS Comput Biol, Vol. 5, No. 9. (18 September 2009), e1000512.
by Rui-Ru Ji, Heshani de Silva, Yisheng Jin, et al.Robert E. Bruccoleri, Jian Cao, Aiqing He, Wenjun Huang, Paul S. Kayne, Isaac M. Neuhaus, Karl-Heinz Ott, Becky Penhallow, Mark I. Cockett, Michael G. Neubauer, Nathan O. Siemers, Petra Ross-Macdonald
|
| |
Drug Discovery Today, Vol. 13, No. 17-18. (September 2008), pp. 816-823.
|
| |
Proceedings of the National Academy of Sciences, Vol. 105, No. 12. (25 March 2008), pp. 4721-4726.
|
| |
Nat Biotech, Vol. 25, No. 1. (08 January 2007), pp. 71-75.
|
| |
Nat Rev Drug Discov, Vol. 8, No. 8. (24 August 2009), pp. 661-677.
|
| |
Nat Chem Biol, Vol. 2, No. 9. (September 2006), pp. 458-466.
|
| |
Mol Syst Biol, Vol. 5 (28 July 2009)
|
| |
Trends in Pharmacological Sciences, Vol. 29, No. 10. (26 October 2008), pp. 499-504.
|
| |
Nat Biotech, Vol. 27, No. 7. (05 July 2009), pp. 659-666.
by Joseph Lehar, Andrew S. Krueger, William Avery, et al.Adrian M. Heilbut, Lisa M. Johansen, E. Roydon Price, Richard J. Rickles, Glenn F. Short III, Jane E. Staunton, Xiaowei Jin, Margaret S. Lee, Grant R. Zimmermann, Alexis A. Borisy
|
| |
Drug Discovery Today, Vol. 13, No. 9-10. (May 2008), pp. 402-408.
|
| |
Pharmacogenomics, Vol. 9, No. 9. (September 2008), pp. 1323-1330.
|
| |
Proceedings of the National Academy of Sciences, Vol. 106, No. 18. (5 May 2009), pp. 7414-7419.
|
| |
Science, Vol. 321, No. 5886. (11 July 2008), pp. 263-266.
|
| |
Nature reviews. Drug discovery, Vol. 8, No. 7. (July 2009), pp. 567-578.
|
| |
Nat Rev Genet, Vol. 5, No. 4. (April 2004), pp. 262-275.
|
| |
Nature genetics, Vol. 38, No. 4. (April 2006), pp. 405-406.
|
| |
Current drug discovery technologies, Vol. 3, No. 4. (December 2006), pp. 269-277.
|
| |
Nat Rev Micro, Vol. 7, No. 6. (June 2009), pp. 460-466.
|
| |
Pharmacogenomics J, Vol. 7, No. 3. (12 September 2006), pp. 180-189.
by L. L. Warren, A. R. Hughes, E. H. Lai, et al.D. V. Zaykin, S. A. Haneline, A. T. Bansal, A. W. Wooster, W. R. Spreen, J. E. Hernandez, T. R. Scott, A. D. Roses, M. Mosteller
|
| |
Pharmacogenomics J, Vol. 9, No. 1. (26 February 2008), pp. 23-33.
|
| |
Nat Rev Cancer, Vol. 6, No. 3. (March 2006), pp. 227-239.
|
| |
Nat Rev Drug Discov, Vol. 8, No. 2. (01 February 2009), pp. 111-128.
|
| |
Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, No. 12. (24 March 2009), pp. 4617-4622.
by S. E. Ong, M. Schenone, A. A. Margolin, et al.X. Li, K. Do, M. K. Doud, D. R. Mani, L. Kuai, X. Wang, J. L. Wood, N. J. Tolliday, A. N. Koehler, L. A. Marcaurelle, T. R. Golub, R. J. Gould, S. L. Schreiber, S. A. Carr
|
| |
Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 15, No. 11. (1 June 2009), pp. 3690-3696.
|
| |
Pharmacogenomics, Vol. 8, No. 5. (May 2007), pp. 425-430.
|
| |
Genome Res, Vol. 15, No. 5. (May 2005), pp. 724-736.
|
| |
Science, Vol. 313, No. 5795. (29 September 2006), pp. 1929-1935.
by Justin Lamb, Emily D. Crawford, David Peck, et al.Joshua W. Modell, Irene C. Blat, Matthew J. Wrobel, Jim Lerner, Jean-Philippe Brunet, Aravind Subramanian, Kenneth N. Ross, Michael Reich, Haley Hieronymus, Guo Wei, Scott A. Armstrong, Stephen J. Haggarty, Paul A. Clemons, Ru Wei, Steven A. Carr, Eric S. Lander, Todd R. Golub
|
| |
Pharmacogenomics, Vol. 9, No. 1. (January 2008), pp. 35-54.
|